Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Tangible Net Worth Ratio

Latest as of June 2026: 91.1%

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd tangible net worth ratio. Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) has a Tangible Net Worth Ratio of 91.1% as of June 2026. This metric is calculated by deducting intangible assets (CN¥71.05 Million) from net assets (CN¥799.00 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Gansu Longshenrongfa Pharmaceutical Indu equity growth rate to track the company's year-over-year net asset growth rate.

Tangible NW Ratio

91.1%
Tangible equity / total equity

Net Assets (Equity)

CN¥799.00 Million
CNY

Intangible Assets

CN¥71.05 Million
Goodwill, patents, brand value

Total Assets

CN¥1.32 Billion
CNY

Tangible Net Worth Ratio of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (2011–2025)

Tangible net worth ratio of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd from 2011 to 2025. This chart shows how Gansu Longshenrongfa Pharmaceutical Industry Co Ltd's Tangible Net Worth Ratio has changed across 15 annual periods from 2011 to 2025. As of June 2026, the ratio stands at 91.1%, reflecting net assets of CN¥799.00 Million with intangible assets of CN¥71.05 Million CNY. Check strategic asset allocation of Gansu Longshenrongfa Pharmaceutical Indu to assess the company's strategic physical and investment asset allocation.

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Tangible Net Worth Ratio by Year (2011–2025)

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd tangible net worth ratio by year from 2011 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd from 2011 to 2025, covering 15 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see market cap of Gansu Longshenrongfa Pharmaceutical Indu.

Year Tangible NW Ratio Net Assets (CNY) Intangible Assets Total Assets Change (pp)
2025 90.9% CN¥781.08 Million CN¥71.46 Million CN¥1.39 Billion ▼ -0.5 pp
2024 91.4% CN¥727.93 Million CN¥62.81 Million CN¥1.40 Billion ▲ +0.1 pp
2023 91.3% CN¥711.51 Million CN¥62.07 Million CN¥1.34 Billion ▼ -1.6 pp
2022 92.8% CN¥763.13 Million CN¥54.74 Million CN¥912.79 Million ▼ -0.2 pp
2021 93.1% CN¥732.84 Million CN¥50.74 Million CN¥824.07 Million ▲ +0.1 pp
2020 93.0% CN¥739.13 Million CN¥52.01 Million CN¥866.66 Million ▲ +0.0 pp
2019 92.9% CN¥738.88 Million CN¥52.15 Million CN¥810.15 Million ▲ +0.3 pp
2018 92.6% CN¥720.83 Million CN¥53.34 Million CN¥778.51 Million ▼ -0.8 pp
2017 93.4% CN¥712.19 Million CN¥46.80 Million CN¥782.23 Million ▲ +0.8 pp
2016 92.6% CN¥703.74 Million CN¥51.77 Million CN¥763.48 Million ▼ -7.0 pp
2015 99.6% CN¥405.57 Million CN¥1.61 Million CN¥646.74 Million ▲ +0.1 pp
2014 99.5% CN¥363.10 Million CN¥1.64 Million CN¥478.49 Million ▲ +0.1 pp
2013 99.5% CN¥318.92 Million CN¥1.71 Million CN¥453.96 Million ▲ +0.6 pp
2012 98.9% CN¥171.46 Million CN¥1.89 Million CN¥294.53 Million ▲ +3.0 pp
2011 95.9% CN¥45.35 Million CN¥1.86 Million CN¥120.49 Million —
pp = percentage points